<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>PoS Bayesian Framework for Pivotal Oncology Trials ‚Ä¢ oncoPoS</title>
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet">
<link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet">
<script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><link href="../extra.css" rel="stylesheet">
<meta property="og:title" content="PoS Bayesian Framework for Pivotal Oncology Trials">
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">oncoPoS</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.1.0</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item"><a class="nav-link" href="../index.html">Home</a></li>
<li class="nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item"><a class="nav-link" href="../articles/oncoPoS.html">Get Started</a></li>
<li class="active nav-item"><a class="nav-link" href="../articles/index.html">Articles</a></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul>
<ul class="navbar-nav">
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/MSDLLCPapers/oncoPoS">Source code</a></li>
      </ul>
</div>


  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>PoS Bayesian Framework for Pivotal Oncology Trials</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/MSDLLCPapers/onsoPoS/blob/main/vignettes/pos_bayes_framework.Rmd" class="external-link"><code>vignettes/pos_bayes_framework.Rmd</code></a></small>
      <div class="d-none name"><code>pos_bayes_framework.Rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="introduction">Introduction<a class="anchor" aria-label="anchor" href="#introduction"></a>
</h2>
<p>Here we describe the Bayesian framework that is used to estimate a
phase 3 efficacy probability of success (PoS) based on work by <span class="citation">Hampson et al. (2022)</span>. The framework consists of
study and population level models that are described in the following
sections.</p>
<p>Let
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>
be a progression-free survival (PFS), and we assume that the log hazard
ratio (HR) of PFS for a phase III study is
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P3}</annotation></semantics></math>.
The subscript 3 denotes the phase of the study (i.e., phase III). In
addition, we assume that data on either the same endpoint
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>
or a different endpoint
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>D</mi><annotation encoding="application/x-tex">D</annotation></semantics></math>
is observed in an earlier phase I/II or phase II study which preceded a
pivotal trial
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P2}</annotation></semantics></math>
or
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>D</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{D2}</annotation></semantics></math>
respectively).</p>
</div>
<div class="section level2">
<h2 id="general-study-level-model">General study level model <a class="anchor" aria-label="anchor" href="#general-study-level-model"></a>
</h2>
<p>The study level model for an observed logHR of PFS in the earlier
study (phase I/II, phase II),
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\hat{\theta}_{P2}</annotation></semantics></math>,
is assumed to have the following form:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>2</mn></mrow></msub><mo>‚àº</mo><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><mo>,</mo><msubsup><mi>‚Ñê</mi><mrow><mi>P</mi><mn>2</mn></mrow><mrow><mo>‚àí</mo><mn>1</mn></mrow></msubsup><mo stretchy="true" form="postfix">)</mo></mrow><mo>,</mo></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align}
\hat{\theta}_{P2} \sim Normal(\theta_{P2}, \mathcal{I}^{-1}_{P2}) \label{eq:ph2_est},
\end{align}</annotation></semantics></math></p>
<p>where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P2}</annotation></semantics></math>
represents a mean treatment effect on
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>
in the earlier study and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>‚Ñê</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\mathcal{I}_{P2}</annotation></semantics></math>
is the Fisher information for
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P2}</annotation></semantics></math>.
Using Bayesian framework, the prior for
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P2}</annotation></semantics></math>
is:
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><mo>‚àº</mo><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œº</mi><mi>P</mi></msub><mo>,</mo><msubsup><mi>œÑ</mi><mrow><mi>P</mi><mn>2</mn></mrow><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow><mo>,</mo></mrow><annotation encoding="application/x-tex">\theta_{P2} \sim Normal (\mu_P, \tau_{P2}^2),</annotation></semantics></math>
where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œº</mi><mi>P</mi></msub><annotation encoding="application/x-tex">\mu_P</annotation></semantics></math>
is a population level parameter for the treatment effect on
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>.
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>œÑ</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\tau_{P2}</annotation></semantics></math>
characterizes the degree of heterogeneity in the treatment effect on
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>
across different earlier studies, which is assumed to follow a
half-Normal distribution:
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>œÑ</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><mo>‚àº</mo><mi>H</mi><mi>N</mi><mrow><mo stretchy="true" form="prefix">(</mo><msubsup><mi>z</mi><mn>2</mn><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow></mrow><annotation encoding="application/x-tex">\tau_{P2} \sim HN(z^2_2)</annotation></semantics></math>.</p>
<p>Similar to the above, a phase III study level model for treatment
effect on endpoint
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P3}</annotation></semantics></math>
has the following distribution:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><mo>‚àº</mo><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œº</mi><mi>P</mi></msub><mo>,</mo><msubsup><mi>œÑ</mi><mrow><mi>P</mi><mn>3</mn></mrow><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align}
\theta_{P3} \sim Normal (\mu_P, \tau_{P3}^2)\label{eq:p3}
\end{align}</annotation></semantics></math></p>
<p>The population level parameter
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œº</mi><mi>P</mi></msub><annotation encoding="application/x-tex">\mu_P</annotation></semantics></math>
is shared across the phases of the clinical development.
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>œÑ</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><annotation encoding="application/x-tex">\tau_{P3}</annotation></semantics></math>
is assumed to follow a half-Normal distribution:
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>œÑ</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><mo>‚àº</mo><mi>H</mi><mi>N</mi><mrow><mo stretchy="true" form="prefix">(</mo><msubsup><mi>z</mi><mn>3</mn><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow></mrow><annotation encoding="application/x-tex">\tau_{P3} \sim HN(z^2_3)</annotation></semantics></math>.
The choice of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>œÑ</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><mo>,</mo><mspace width="0.222em"></mspace><msub><mi>œÑ</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub></mrow><annotation encoding="application/x-tex">\tau_{P2},\ \tau_{P3}</annotation></semantics></math>
will follow Supplementary Materials E in <span class="citation">Hampson
et al. (2022)</span>.</p>
</div>
<div class="section level2">
<h2 id="population-level-model">Population level model <a class="anchor" aria-label="anchor" href="#population-level-model"></a>
</h2>
<p>The population level treatment effect,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œº</mi><mi>P</mi></msub><annotation encoding="application/x-tex">\mu_P</annotation></semantics></math>,
is assumed to come from a mixture prior:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mi>Œº</mi><mi>P</mi></msub><mo>‚àº</mo><mi>œâ</mi><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œ¥</mi><mi>P</mi></msub><mo>,</mo><msubsup><mi>œÉ</mi><mrow><mi>P</mi><mn>1</mn></mrow><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow><mo>+</mo><mrow><mo stretchy="true" form="prefix">(</mo><mn>1</mn><mo>‚àí</mo><mi>œâ</mi><mo stretchy="true" form="postfix">)</mo></mrow><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><mn>0</mn><mo>,</mo><msubsup><mi>œÉ</mi><mrow><mi>P</mi><mn>2</mn></mrow><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow><mo>,</mo></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align}
\mu_{P} \sim \omega Normal (\delta_{P}, \sigma_{P1}^2) + (1-\omega) Normal(0, \sigma_{P2}^2) ,
\end{align}</annotation></semantics></math></p>
<p>with the following components:</p>
<ul>
<li><p><math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>w</mi><annotation encoding="application/x-tex">w</annotation></semantics></math>
is a probability that
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œº</mi><mi>P</mi></msub><annotation encoding="application/x-tex">\mu_P</annotation></semantics></math>
comes from the enthusiastic prior component. The value of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>w</mi><annotation encoding="application/x-tex">w</annotation></semantics></math>
is determined by the industry benchmark.</p></li>
<li><p><math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œ¥</mi><mi>P</mi></msub><mo>,</mo><msubsup><mi>œÉ</mi><mrow><mi>P</mi><mn>1</mn></mrow><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow></mrow><annotation encoding="application/x-tex">Normal(\delta_P, \sigma^2_{P1})</annotation></semantics></math>
is the enthusiastic component, i.e., a distribution which is centered at
the target treatment effect
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ¥</mi><mi>P</mi></msub><annotation encoding="application/x-tex">\delta_P</annotation></semantics></math>
(i.e., alternative hypothesis).
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msubsup><mi>œÉ</mi><mrow><mi>P</mi><mn>1</mn></mrow><mn>2</mn></msubsup><annotation encoding="application/x-tex">\sigma^2_{P1}</annotation></semantics></math>
is set as a solution to:
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>P</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œº</mi><mi>P</mi></msub><mo>‚â•</mo><mn>0</mn><mo stretchy="false" form="prefix">|</mo><mi>œâ</mi><mo>=</mo><mn>1</mn><mo stretchy="true" form="postfix">)</mo></mrow><mo>=</mo><mi>Œ≥</mi></mrow><annotation encoding="application/x-tex">P(\mu_P \ge 0 | \omega = 1)=\gamma</annotation></semantics></math>,
which is consistent with the interpretation of the enthusiastic
(‚Äúalternative‚Äù) component,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>‚áî</mo><msub><mi>œÉ</mi><mrow><mi>P</mi><mn>1</mn></mrow></msub><mo>=</mo><mfrac><msub><mi>Œ¥</mi><mi>P</mi></msub><mrow><msup><mi>Œ¶</mi><mrow><mo>‚àí</mo><mn>1</mn></mrow></msup><mrow><mo stretchy="true" form="prefix">(</mo><mi>Œ≥</mi><mo stretchy="true" form="postfix">)</mo></mrow></mrow></mfrac></mrow><annotation encoding="application/x-tex">\Leftrightarrow \sigma_{P1} = \frac{\delta_P}{\Phi^{-1}(\gamma)}</annotation></semantics></math>.</p></li>
<li><p><math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><mn>0</mn><mo>,</mo><msubsup><mi>œÉ</mi><mrow><mi>P</mi><mn>2</mn></mrow><mn>2</mn></msubsup><mo stretchy="true" form="postfix">)</mo></mrow></mrow><annotation encoding="application/x-tex">Normal(0, \sigma^2_{P2})</annotation></semantics></math>
is the skeptical component, i.e., a distribution which is centered at
the null hypothesis.
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msubsup><mi>œÉ</mi><mrow><mi>P</mi><mn>2</mn></mrow><mn>2</mn></msubsup><annotation encoding="application/x-tex">\sigma^2_{P2}</annotation></semantics></math>
is set as a solution to:
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>P</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œº</mi><mi>P</mi></msub><mo>‚â§</mo><msub><mi>Œ¥</mi><mi>P</mi></msub><mo stretchy="false" form="prefix">|</mo><mi>œâ</mi><mo>=</mo><mn>0</mn><mo stretchy="true" form="postfix">)</mo></mrow><mo>=</mo><mi>Œ≥</mi></mrow><annotation encoding="application/x-tex">P(\mu_P \le \delta_P | \omega = 0)=\gamma</annotation></semantics></math>,
which is consistent with the interpretation of the skeptical (‚Äúnull‚Äù)
component,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>‚áî</mo><msub><mi>œÉ</mi><mrow><mi>P</mi><mn>2</mn></mrow></msub><mo>=</mo><mfrac><msub><mi>Œ¥</mi><mi>P</mi></msub><mrow><msup><mi>Œ¶</mi><mrow><mo>‚àí</mo><mn>1</mn></mrow></msup><mrow><mo stretchy="true" form="prefix">(</mo><mi>Œ≥</mi><mo stretchy="true" form="postfix">)</mo></mrow></mrow></mfrac></mrow><annotation encoding="application/x-tex">\Leftrightarrow \sigma_{P2} = \frac{\delta_P}{\Phi^{-1}(\gamma)}</annotation></semantics></math>.</p></li>
</ul>
<p>When
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>
denotes the logHR of PFS,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>Œ≥</mi><annotation encoding="application/x-tex">\gamma</annotation></semantics></math>
is the probability that the population level treatment effect is equal
to or worse than the null (i.e., logHR is
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>‚â•</mo><mn>0</mn></mrow><annotation encoding="application/x-tex">\ge 0</annotation></semantics></math>)
when the benchmarking data indicate an optimistic expectation of the
treatment effect; or the probability that the population level treatment
effect is equal to or better than the target effect in phase III (i.e.,
logHR is
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>‚â§</mo><msub><mi>Œ¥</mi><mi>P</mi></msub></mrow><annotation encoding="application/x-tex">\le \delta_P</annotation></semantics></math>)
when the benchmarking data indicate we should have pessimistic
expectation of the treatment effect.
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>Œ≥</mi><annotation encoding="application/x-tex">\gamma</annotation></semantics></math>
should be set to a small number so that the probability of either lack
treatment effect under the enthusiastic prior or substaintial treatment
effect under the pessimistic prior is small.</p>
</div>
<div class="section level2">
<h2 id="phase-iii-efficacy-pos-prediction">Phase III efficacy PoS prediction <a class="anchor" aria-label="anchor" href="#phase-iii-efficacy-pos-prediction"></a>
</h2>
<p>After fitting the models that are outlined above, we can generate a
phase III efficacy PoS prediction based on the distribution of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P3}</annotation></semantics></math>.</p>
<p>Let
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>J</mi><annotation encoding="application/x-tex">J</annotation></semantics></math>
denotes the number of analyses considered in a group sequential design
for a future phase III study. For instance, if
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>J</mi><mo>=</mo><mn>2</mn></mrow><annotation encoding="application/x-tex">J = 2</annotation></semantics></math>,
this means that a study has one interim analysis (IA) and one final
analysis (FA). The distribution of the observed log HR for endpoint
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>P</mi><annotation encoding="application/x-tex">P</annotation></semantics></math>
at the
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>j</mi><annotation encoding="application/x-tex">j</annotation></semantics></math>-th
analysis,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>3</mn><mi>j</mi></mrow></msub><mo>,</mo><mi>j</mi><mo>=</mo><mn>1</mn><mo>,</mo><mi>.</mi><mi>.</mi><mi>.</mi><mo>,</mo><mi>J</mi></mrow><annotation encoding="application/x-tex">\hat{\theta}_{P3j}, j = 1, ..., J</annotation></semantics></math>
is as follows:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mover><mi>ùõâ</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>3</mn></mrow></msub><mo>‚àº</mo><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><msub><mn>ùüè</mn><mi>J</mi></msub><mo>,</mo><msub><mi>ùö∫</mi><mrow><mi>J</mi><mo>√ó</mo><mi>J</mi></mrow></msub><mo stretchy="true" form="postfix">)</mo></mrow><mo>,</mo></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align}
\hat{\boldsymbol{\theta}}_{P3} \sim Normal ({\theta}_{P3}\mathbf{1}_{J}, \mathbf{\Sigma}_{J \times J})\label{eq:thetahat_samp},
\end{align}</annotation></semantics></math></p>
<p>where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mn>3</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{P3}</annotation></semantics></math>
is the underlying true log hazard ratio for all
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>J</mi><annotation encoding="application/x-tex">J</annotation></semantics></math>
analyses.
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>ùö∫</mi><annotation encoding="application/x-tex">\mathbf{\Sigma}</annotation></semantics></math>
is the covariance matrix that encodes the Fisher‚Äôs information for
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>3</mn><mi>j</mi></mrow></msub><annotation encoding="application/x-tex">\hat{\theta}_{P3j}</annotation></semantics></math>:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mi>ùö∫</mi><mrow><mi>i</mi><mi>j</mi></mrow></msub><mo>=</mo><mfrac><msubsup><mi>œÉ</mi><mrow><mi>u</mi><mi>n</mi><mi>i</mi><mi>t</mi></mrow><mn>2</mn></msubsup><msub><mi>n</mi><mi>j</mi></msub></mfrac><mo>,</mo><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><mrow><mtext mathvariant="normal">for all </mtext><mspace width="0.333em"></mspace></mrow><mi>i</mi><mo>‚â§</mo><mi>j</mi><mo>,</mo></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align}
\mathbf{\Sigma}_{ij} = \frac{\sigma_{unit}^2}{n_j}, ~~ \text{for all } i \leq j\label{eq:sigma},
\end{align}</annotation></semantics></math></p>
<p>with
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>n</mi><mi>j</mi></msub><annotation encoding="application/x-tex">n_j</annotation></semantics></math>
being the target number of events at the
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>j</mi><annotation encoding="application/x-tex">j</annotation></semantics></math>-th
analysis and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msubsup><mi>œÉ</mi><mrow><mi>u</mi><mi>n</mi><mi>i</mi><mi>t</mi></mrow><mn>2</mn></msubsup><mo>=</mo><mfrac><mn>1</mn><mrow><msub><mi>p</mi><mn>0</mn></msub><mrow><mo stretchy="true" form="prefix">(</mo><mn>1</mn><mo>‚àí</mo><msub><mi>p</mi><mn>0</mn></msub><mo stretchy="true" form="postfix">)</mo></mrow></mrow></mfrac></mrow><annotation encoding="application/x-tex">\sigma_{unit}^2 = \frac{1}{p_0(1-p_0)}</annotation></semantics></math>
where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>p</mi><mn>0</mn></msub><annotation encoding="application/x-tex">p_0</annotation></semantics></math>
is the planned proportion of patients in the control group.</p>
<p>The predicted treatment effect
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msubsup><mover><mi>ùõâ</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>3</mn></mrow><mrow><mo stretchy="true" form="prefix">(</mo><mi>l</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><annotation encoding="application/x-tex">\hat{\boldsymbol{\theta}}_{P3}^{(l)}</annotation></semantics></math>
is generated
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>L</mi><annotation encoding="application/x-tex">L</annotation></semantics></math>
times
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>l</mi><mo>=</mo><mn>1</mn><mo>,</mo><mi>‚Ä¶</mi><mo>,</mo><mi>L</mi></mrow><annotation encoding="application/x-tex">l = 1, \dots, L</annotation></semantics></math>)
based on the Bayesian hierarchical model and the success at the
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>j</mi><annotation encoding="application/x-tex">j</annotation></semantics></math>-th
analysis is determined by a Frequentest efficacy boundary,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>z</mi><mrow><mi>P</mi><mn>3</mn><mi>j</mi></mrow></msub><annotation encoding="application/x-tex">z_{P3j}</annotation></semantics></math>.
Thus, the probability of stopping a phase III trial for efficacy at the
first IA is estimated as:
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mover><mrow><mi>P</mi><mi>o</mi><mi>S</mi></mrow><mo accent="true">ÃÇ</mo></mover><mn>31</mn></msub><mo>=</mo><mfrac><mn>1</mn><mi>L</mi></mfrac><munderover><mo>‚àë</mo><mrow><mi>l</mi><mo>=</mo><mn>1</mn></mrow><mi>L</mi></munderover><mi>I</mi><mrow><mo stretchy="true" form="prefix">(</mo><msubsup><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>31</mn></mrow><mrow><mo stretchy="true" form="prefix">(</mo><mi>l</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>&lt;</mo><msub><mi>z</mi><mrow><mi>P</mi><mn>31</mn></mrow></msub><mo stretchy="true" form="postfix">)</mo></mrow><mo>,</mo></mrow><annotation encoding="application/x-tex">
\hat{PoS}_{31} = \frac{1}{L} \sum_{l=1}^L I(\hat{\theta}_{P31}^{(l)} &lt; z_{P31}),
</annotation></semantics></math> and the probability of stopping a phase
III trial for efficacy at the
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msup><mi>j</mi><mrow><mi>t</mi><mi>h</mi></mrow></msup><annotation encoding="application/x-tex">j^{th}</annotation></semantics></math>
analysis is estimated as:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mover><mrow><mi>P</mi><mi>o</mi><mi>S</mi></mrow><mo accent="true">ÃÇ</mo></mover><mrow><mn>3</mn><mi>j</mi></mrow></msub><mo>=</mo><mfrac><mn>1</mn><mi>L</mi></mfrac><munderover><mo>‚àë</mo><mrow><mi>l</mi><mo>=</mo><mn>1</mn></mrow><mi>L</mi></munderover><mi>I</mi><mrow><mo stretchy="true" form="prefix">(</mo><msubsup><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>3</mn><mi>j</mi></mrow><mrow><mo stretchy="true" form="prefix">(</mo><mi>l</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>&lt;</mo><msub><mi>z</mi><mrow><mi>P</mi><mn>3</mn><mi>j</mi></mrow></msub><mo>,</mo><msubsup><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>P</mi><mn>3</mn><mi>i</mi></mrow><mrow><mo stretchy="true" form="prefix">(</mo><mi>l</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>‚â•</mo><msub><mi>z</mi><mrow><mi>P</mi><mn>3</mn><mi>i</mi></mrow></msub><mo>,</mo><mi>i</mi><mo>=</mo><mn>1</mn><mo>,</mo><mi>‚Ä¶</mi><mo>,</mo><mi>j</mi><mo>‚àí</mo><mn>1</mn><mo stretchy="true" form="postfix">)</mo></mrow><mi>.</mi></mrow><annotation encoding="application/x-tex">
\hat{PoS}_{3j} = \frac{1}{L} \sum_{l=1}^L I(\hat{\theta}_{P3j}^{(l)} &lt; z_{P3j}, \hat{\theta}_{P3i}^{(l)} \geq z_{P3i}, i = 1, \dots, j-1).
</annotation></semantics></math> Finally, the overall PoS is:
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mover><mrow><mi>P</mi><mi>o</mi><mi>S</mi></mrow><mo accent="true">ÃÇ</mo></mover><mn>3</mn></msub><mo>=</mo><msubsup><mo>‚àë</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><mi>J</mi></msubsup><msub><mover><mrow><mi>P</mi><mi>o</mi><mi>S</mi></mrow><mo accent="true">ÃÇ</mo></mover><mrow><mn>3</mn><mi>j</mi></mrow></msub></mrow><annotation encoding="application/x-tex">\hat{PoS}_{3} = \sum_{j=1}^J \hat{PoS}_{3j}</annotation></semantics></math>.</p>
</div>
<div class="section level2">
<h2 id="study-level-model-when-phase-iii-primary-endpoint-is-not-available-from-earlier-studyies">Study level model when phase III primary endpoint is not available
from earlier study(ies) <a class="anchor" aria-label="anchor" href="#study-level-model-when-phase-iii-primary-endpoint-is-not-available-from-earlier-studyies"></a>
</h2>
<p>When an early study didn‚Äôt have a reliable PFS estimate, and only ORR
is available from a randomized controlled phase II study, it can be used
for PoS estimation instead. Let
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{ORR,2}</annotation></semantics></math>
represents a log odds ratio (OR) of the treatment effect on ORR, the
observed treatment effect,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\hat{\theta}_{ORR, 2}</annotation></semantics></math>,
has the following distribution:
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><mo>‚àº</mo><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œ∏</mi><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><mo>,</mo><msubsup><mi>‚Ñê</mi><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow><mrow><mo>‚àí</mo><mn>1</mn></mrow></msubsup><mo stretchy="true" form="postfix">)</mo></mrow><mo>,</mo></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align}
\hat{\theta}_{ORR, 2} \sim Normal(\theta_{ORR, 2}, \mathcal{I}_{ORR, 2}^{-1}),
\end{align}</annotation></semantics></math> where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>‚Ñê</mi><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\mathcal{I}_{ORR, 2}</annotation></semantics></math>
is the Fisher information associated with
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mover><mi>Œ∏</mi><mo accent="true">ÃÇ</mo></mover><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\hat{\theta}_{ORR, 2}</annotation></semantics></math>.
Further, let
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mi>F</mi><mi>S</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{PFS, 2}</annotation></semantics></math>
be the treatment effect for PFS in Phase II. Motivated by the results in
<span class="citation">Blumenthal et al. (2015)</span>, we assume the
following linear model between the PFS and ORR treatment effects:
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mi>Œ∏</mi><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><mo>‚àº</mo><mi>N</mi><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>Œ≤</mi><mn>0</mn></msub><mo>+</mo><msub><mi>Œ≤</mi><mn>1</mn></msub><msub><mi>Œ∏</mi><mrow><mi>P</mi><mi>F</mi><mi>S</mi><mo>,</mo><mn>2</mn></mrow></msub><mo>,</mo><mfrac><msubsup><mi>œÉ</mi><mrow><mi>W</mi><mi>L</mi><mi>S</mi></mrow><mn>2</mn></msubsup><msub><mi>N</mi><mrow><mi>p</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>s</mi></mrow></msub></mfrac><mo stretchy="true" form="postfix">)</mo></mrow><mo>,</mo></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align}
  \theta_{ORR,2} \sim N(\beta_0 + \beta_1 \theta_{PFS,2}, \frac{\sigma_{WLS}^2}{N_{patients}}), \label{eq:ph23_pfs_orr_rel}
\end{align}</annotation></semantics></math> where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>N</mi><mrow><mi>p</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>s</mi></mrow></msub><annotation encoding="application/x-tex">N_{patients}</annotation></semantics></math>
is the number of patients in a given trial and the regression parameters
are assigned the following priors:
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right" style="text-align: right"><msub><mi>Œ≤</mi><mn>0</mn></msub><mo>‚àº</mo><mrow><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi></mrow><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>m</mi><mn>0</mn></msub><mo>,</mo><msub><mi>ŒΩ</mi><mn>0</mn></msub><mo stretchy="true" form="postfix">)</mo></mrow></mtd></mtr><mtr><mtd columnalign="right" style="text-align: right"><msub><mi>Œ≤</mi><mn>1</mn></msub><mo>‚àº</mo><mrow><mi>N</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi></mrow><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>m</mi><mn>1</mn></msub><mo>,</mo><msub><mi>ŒΩ</mi><mn>1</mn></msub><mo stretchy="true" form="postfix">)</mo></mrow><mi>.</mi></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{align*}
\beta_0 \sim {Normal}(m_0, \nu_0) \\
\beta_1 \sim {Normal}(m_1, \nu_1). 
\end{align*}</annotation></semantics></math> The values of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>m</mi><mn>0</mn></msub><mo>,</mo><msub><mi>m</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">m_0, m_1</annotation></semantics></math>,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>ŒΩ</mi><mn>0</mn></msub><mo>,</mo><msub><mi>ŒΩ</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">\nu_0, \nu_1</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msubsup><mi>œÉ</mi><mrow><mi>W</mi><mi>L</mi><mi>S</mi></mrow><mn>2</mn></msubsup><annotation encoding="application/x-tex">\sigma_{WLS}^2</annotation></semantics></math>
are determined from historical data, which is provided in the
meta-analysis in <span class="citation">Blumenthal et al. (2015)</span>.
Specifically,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>m</mi><mn>0</mn></msub><mo>,</mo><msub><mi>m</mi><mn>1</mn></msub><mo stretchy="true" form="postfix">)</mo></mrow><annotation encoding="application/x-tex">(m_0, m_1)</annotation></semantics></math>
are point estimates for the intercept and slope from a weighted liner
simple (WLS) linear regression model of log(HR PFS) on log(OR ORR),
while
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo stretchy="true" form="prefix">(</mo><msub><mi>ŒΩ</mi><mn>0</mn></msub><mo>,</mo><msub><mi>ŒΩ</mi><mn>1</mn></msub><mo stretchy="true" form="postfix">)</mo></mrow><annotation encoding="application/x-tex">(\nu_0, \nu_1)</annotation></semantics></math>
are their respective SEs,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msubsup><mi>œÉ</mi><mrow><mi>W</mi><mi>L</mi><mi>S</mi></mrow><mn>2</mn></msubsup><annotation encoding="application/x-tex">\sigma_{WLS}^2</annotation></semantics></math>
is estimated based on WLS regression residual variance.</p>
<p>Based on the approximated correlation between
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>O</mi><mi>R</mi><mi>R</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{ORR, 2}</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mi>F</mi><mi>S</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{PFS, 2}</annotation></semantics></math>,
a distribution for
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>Œ∏</mi><mrow><mi>P</mi><mi>F</mi><mi>S</mi><mo>,</mo><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">\theta_{PFS, 2}</annotation></semantics></math>
can be obtained and, therefore, a predicated efficacy PoS can be
estimated as using models that are outlined above.</p>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-blumenthal2015overall" class="csl-entry">
Blumenthal, Gideon M, Stella W Karuri, Hui Zhang, Lijun Zhang, Sean
Khozin, Dickran Kazandjian, Shenghui Tang, Rajeshwari Sridhara, Patricia
Keegan, and Richard Pazdur. 2015. <span>‚ÄúOverall Response Rate,
Progression-Free Survival, and Overall Survival with Targeted and
Standard Therapies in Advanced Non‚ÄìSmall-Cell Lung Cancer: US Food and
Drug Administration Trial-Level and Patient-Level Analyses.‚Äù</span>
<em>Journal of Clinical Oncology</em> 33 (9): 1008.
</div>
<div id="ref-hampson2022improving" class="csl-entry">
Hampson, Lisa V, Bj√∂rn Bornkamp, Bj√∂rn Holzhauer, Joseph Kahn, Markus R
Lange, Wen-Lin Luo, Giovanni Della Cioppa, Kelvin Stott, and Steffen
Ballerstedt. 2022. <span>‚ÄúImproving the Assessment of the Probability of
Success in Late Stage Drug Development.‚Äù</span> <em>Pharmaceutical
Statistics</em> 21 (2): 439‚Äì59.
</div>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p>Developed by Yulia Sidi, Xiang Peng, Alex Ziyu Jiang. Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.2.0. <br>Copyright ¬© 2026 Merck &amp; Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.</p>
</div>

<div class="pkgdown-footer-right">
  <p><span></span></p>
</div>

    </footer>
</div>





  </body>
</html>
